Dr. Ferzaan Engineer – Cancer Speciality Hospital

Ferzaan Engineer PhD is Co-founder and Chairman of Cytecare Hospitals Private Limited. He is also Co-founder and Jt. Chairman of Medwell Ventures, a Home Healthcare company offering services under the Nightingales brand. He serves as a Director of Cytespace Research Private Limited. Until 2010, Ferzaan served as CEO of Quintiles Research (India) Private Limited and was a member of the Asia-Pacific Management Board of Quintiles. He has also served on the Board of Cenduit LLC. He currently serves on the Board of Directors of Sun Pharma Advanced Research Company (SPARC) and as Mentor at Escape Velocity Accelerator in Bangalore. A pharmacy graduate from the LM College in Ahmedabad, Ferzaan completed his PhD in Pharmaceutical Sciences from the College of Pharmacy at the University of South Carolina, USA. He attended executive management programmes at the Kenan-Flagler Business School (USA), IIMA (India) and INSEAD (France).

Ferzaan previously worked as Assistant Professor of Pharmaceutical Sciences in the United States, followed by an industry position as R&D head for Core Healthcare. Ferzaan has been a member of professional bodies such as AAPS and AACP. He received the AACP New Investigator’s Award in 1990 and received research grants from the National Institutes of Health, USA. He has published papers in leading international journals and lectured at several international conferences and at management schools. He has served on the Advisory Board of the Indian Society for Clinical Research (ISCR) and has been a member of the CII National Committee on Drugs and Pharmaceuticals and the FICCI Pharmaceuticals and Biotechnology Committee.

Ferzaan lives in Bangalore with his two children, Anaya (15) and Varun (22). His hobbies include travel, photography, jazz and modern art.

More details about his state of the art cancer facility in Bangalore are available at www.cytecare.com

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.